Company: DMAAR
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076681
Chunk: 141

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 4
Chunk 141
---
:NonRedeemableOrdinaryShareMember

    2025-04-01
    2025-06-30

    0002028614
    
      dmaau:NonRedeemableOrdinaryShareMember

    2025-01-01
    2025-06-30

    0002028614
    
      dmaau:NonRedeemableOrdinaryShareMember

    2024-05-23
    2024-06-30

    0002028614
    
      us-gaap:CommonStockMember

    2024-12-31

    0002028614
    
      us-gaap:ReceivablesFromStockholderMember

    2024-12-31

    0002028614
    
      us-gaap:AdditionalPaidInCapitalMember

    2024-12-31

    0002028614
    
      us-gaap:RetainedEarningsMember

    2024-12-31

    0002028614
    
      us-gaap:CommonStockMember

    2025-01-01
    2025-03-31

    0002028614
    
      us-gaap:ReceivablesFromStockholderMember

    2025-01-01
    2025-03-31

    0002028614
    
      us-gaap:AdditionalPaidInCapitalMember

    2025-01-01
    2025-03-31

    0002028614
    
      us-gaap:RetainedEarningsMember

    2025-01-01
    2025-03-31

    0002028614

    2025-01-01
    2025-03-31

    0002028614
    
      us-gaap:CommonStockMember

    2025-03-31

    0002028614
    
      us-gaap:ReceivablesFromStockholderMember

    2025-03-31

    0002028614
    
      us-gaap:AdditionalPaidInCapitalMember

    2025-03-31

    0002028614
    
      us-gaap:RetainedEarningsMember

    2025-03-31

    000202861